Biotech

Unexpected Protein Structure May Lead to New Cancer Treatments

University of Iowa researchers have uncovered an unexpected double-ring structure in the DNA repair protein RAD52, revealing new insights that could guide the development of next-generation cancer drugs.

Cyclana Bio Secures £5M to Transform Drug Discovery for Endometriosis

Cambridge-based biotech pioneers tissue-level approach to women's health, aiming to close the gender gap in medical innovation.

Bio-Rad and Gencurix Expand European Access to Precision Cancer Testing

Exclusive distribution deal will bring Droplex digital PCR diagnostic kits to more laboratories across Europe, supporting biomarker-driven treatment decisions in major cancers.

Tagomics Breakthrough Study Showcases New Epigenomic Profiling Technology in Cell Reports Methods

Cambridge biotech’s Activace™ platform offers a scalable, DNA-preserving method to unlock cancer biomarkers from liquid biopsies

Genmab to Acquire Merus in $8B Deal, Adding Breakthrough Oncology Asset to Late-Stage Pipeline

$8B acquisition brings late-stage bispecific antibody petosemtamab into Genmab’s pipeline, accelerating shift to a wholly owned model with potential blockbuster launches by 2027.

N4 Pharma and SRI Advance Targeted RNA Delivery with Nuvec® Platform for Cancer Therapies

Collaboration with SRI demonstrates Nuvec®’s ability to selectively deliver RNA to cancer cells, advancing prospects for targeted, orally delivered RNA therapeutics.